Decheng Capital as of Dec. 31, 2025
Portfolio Holdings for Decheng Capital
Decheng Capital holds 19 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 35.6 | $265M | 6.4M | 41.52 | |
| Nuvation Bio (NUVB) | 31.3 | $233M | 26M | 8.96 | |
| Upstream Bio (UPB) | 11.5 | $85M | 3.1M | 27.15 | |
| Aardvark Therapeutics (AARD) | 6.9 | $51M | 3.9M | 13.12 | |
| Lyell Immunopharma | 2.9 | $21M | 692k | 30.78 | |
| Newamsterdam Pharma Co Nv (NAMS) | 2.8 | $21M | 592k | 35.08 | |
| Revolution Medicines (RVMD) | 2.1 | $16M | 200k | 79.65 | |
| Arcus Biosciences Incorporated (RCUS) | 1.7 | $13M | 542k | 23.83 | |
| Aclaris Therapeutics (ACRS) | 1.6 | $12M | 4.0M | 3.01 | |
| Equillium (EQ) | 0.9 | $6.9M | 4.4M | 1.55 | |
| BeyondSpring SHS (BYSI) | 0.8 | $6.2M | 3.8M | 1.63 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.6 | $4.3M | 93k | 46.55 | |
| Krystal Biotech (KRYS) | 0.6 | $4.3M | 17k | 246.54 | |
| Aura Biosciences (AURA) | 0.3 | $2.0M | 361k | 5.45 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.2 | $1.8M | 1.3M | 1.35 | |
| Pyxis Oncology (PYXS) | 0.1 | $376k | 327k | 1.15 | |
| 4d Molecular Therapeutics In (FDMT) | 0.0 | $332k | 44k | 7.50 | |
| Nuvation Bio Warrants (NUVB.WS) | 0.0 | $213k | 646k | 0.33 | |
| Rezolute (RZLT) | 0.0 | $141k | 60k | 2.36 |
